MILAN, Italy, February 1, 2023 - The Discovery Biology Unit at Dompé farmaceutici, in collaboration with Università degli Studi dell’Aquila, has published in December on Frontiers in Oncology a review ...
HENDERSON, Nev., Feb. 6, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) Volition a multi-national epigenetics company, announces its first commercial sale of Volition's High Throughput ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results